Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Oxford, Oxfordshire, United Kingdom Clinical Trials

A listing of Oxford, Oxfordshire, United Kingdom clinical trials actively recruiting patients volunteers.

RESULTS

Found (6) clinical trials

A Comparison of Standard Laser With Micropulse Laser for the Treatment of Diabetic Macular Oedema.

Background Laser has been the treatment of choice for people with Diabetic Macular Oedema (DMO) since its beneficial effects were demonstrated by the ETDRS in 1985 [1]. In a recent appraisal [2], The National Institute of Health and Care Excellence (NICE) recommended the continued use of standard threshold laser to ...

Phase N/A

0.0 miles

Learn More »

Effects of a Brief Mental Exercise on Emotional Processing

Background and objective: Previous research indicates that various physiological treatments for depression (especially antidepressant drugs) can induce positive biases in emotional information processing and it has been suggested that this might be a crucial common mechanism through which they exert their clinical effects. In this study we aim to investigate ...

Phase N/A

1.77 miles

Learn More »

RESCEU: Defining the Burden of RSV Disease

Infants will be recruited into one of two cohorts: Passive (around 1800 participants) - Demographic data will be collected at inclusion and a parental questionnaire at one year of age. Infants admitted to a hospital with an acute respiratory tract illness will be followed up to the age of 3 ...

Phase N/A

1.82 miles

Learn More »

Efficacy Safety & Utilisation of Nuwiq Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients

Octapharma's FVIII concentrates have been tested in clinical trials and registered for treatment of haemophilia A; however, as haemophilia A is a rare disease, the numbers of patients treated in studies so far are limited. For previously untreated patients (PUPs), who are typically young children, and for minimally treated patients ...

Phase N/A

1.82 miles

Learn More »

A Safety Study of NUC-3373 in Combination With Standard Agents Used in Colorectal Cancer Treatment

This is a two-part study of NUC-3373 administered every 2 weeks as an intravenous infusion, in separate combinations with leucovorin, oxaliplatin, oxaliplatin + bevacizumab, oxaliplatin + panitumumab, irinotecan, and irinotecan + cetuximab. The primary objective is to identify a recommended dose for NUC-3373 when combined with these agents.

Phase

1.86 miles

Learn More »

A Study Exploring Whooping Cough Protection in Children and Adults

The study will be performed in three European countries (UK, Finland and the Netherlands) with a different epidemiological background for pertussis incidence and different age groups will have had different primary schedules with whole cell pertussis (wP) or aP vaccines in their first year of life. Long-term memory responses will ...

Phase

1.86 miles

Learn More »